About VivArt-X
VivArt-X is a company based in Eindhoven (Netherlands) founded in 2022 by Dan Jing Wu and Patricia Dankers. VivArt-X has raised $2.23 million across 2 funding rounds from investors including BOM, TU Eindhoven and Brabant. VivArt-X offers products and services including Regenerative Biomaterial. VivArt-X operates in a competitive market with competitors including Sientra, Establishment Labs, GC Aesthetics, BioAesthetics and AirXpanders, among others.
- Headquarter Eindhoven, Netherlands
- Founders Dan Jing Wu, Patricia Dankers
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.23 M (USD)
in 2 rounds
-
Latest Funding Round
$1.51 M (USD), Seed
Dec 05, 2023
-
Investors
BOM
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VivArt-X
VivArt-X offers a comprehensive portfolio of products and services, including Regenerative Biomaterial.
Synthetic material for personalized breast tissue regeneration.
Funding Insights of VivArt-X
VivArt-X has successfully raised a total of $2.23M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.51 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in VivArt-X
VivArt-X has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include BOM, TU Eindhoven and Brabant.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed by BOM toward early and growth-stage firms.
|
Locked | Locked | Locked | |
|
Road planning services are provided across North Brabant province.
|
Locked | Locked | Locked | |
|
University offering multiple courses and degrees across diversified streams
|
Locked | Locked | Locked |
Investor details for VivArt-X
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VivArt-X
Investment portfolio details for VivArt-X
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VivArt-X
Detailed financials for VivArt-X
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vivart-X Comparisons
Peer comparison for VivArt-X
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VivArt-X
VivArt-X operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sientra, Establishment Labs, GC Aesthetics, BioAesthetics and AirXpanders, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Products for plastic surgery and aesthetics are developed and marketed.
|
|
| Locked | Locked | Locked |
Silicone-filled breast and body shaping implants are designed and manufactured.
|
|
| Locked | Locked | Locked |
Silicone breast implants are developed for reconstruction and aesthetic surgery.
|
|
| Locked | Locked | Locked |
Tissue-engineered nipple-areolar complexes are developed for post-mastectomy use.
|
|
| Locked | Locked | Locked |
Tissue expansion technology for breast reconstruction surgery is developed.
|
|
| Locked | Locked | Locked |
Surgical meshes for treating women's urinary incontinence are developed.
|
Detailed competitors of VivArt-X
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vivart-X
Complete news archive for VivArt-X
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VivArt-X
VivArt-X was founded in 2022 and raised its 1st funding round 1 year after it was founded.
VivArt-X is headquartered in Eindhoven, Netherlands. It is registered at Eindhoven, Noord-brabant, Netherlands.
Dan Jing Wu is the current CEO of VivArt-X. They have also founded this company.
VivArt-X is a funded company, having raised a total of $2.23M across 2 funding rounds to date.
VivArt-X was founded in 2022 in Eindhoven, Netherlands, within the biotechnology sector. Synthetic, degradable biomaterials are developed for womens health applications. Personalized breast reconstruction and tissue regeneration are supported through these materials. Operations center on research and development of regenerative solutions, with co-founders Dan Jing Wu as CEO and Patricia Dankers contributing to the initiative.
VivArt-X's top competitors include Establishment Labs, GC Aesthetics and Sientra.
VivArt-X offers Regenerative Biomaterial.
VivArt-X has 3 investors. Key investors include BOM, TU Eindhoven, and Brabant.